Adaptive Biotechnologies Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Adaptive Biotechnologies Corp
CIK #0001478320
EDGAR Form CIK 2011 - 2026
10-K [0001478320]
10-Q [0001478320]
3 [0001478320]
4 [0001478320]
5 [0001478320]
8-K [0001478320]
D [0001478320]
SC 13G [0001478320]
Form 13D/13G Filer Form 13D/13G Subject Filed
Ark Investment Management LLC Adaptive Biotechnologies Corp [2025-05-14]
Rubric Capital Management LP Adaptive Biotechnologies Corp [2024-11-13]
Nikko Asset Management Americas Inc Adaptive Biotechnologies Corp [2024-11-08]
Sumitomo Mitsui Trust Group Inc Adaptive Biotechnologies Corp [2024-11-05]
Vanguard Group Inc Adaptive Biotechnologies Corp [2024-11-04]
Integrated Core Strategies US LLC Adaptive Biotechnologies Corp [2024-05-28]
BlackRock Inc Adaptive Biotechnologies Corp [2024-01-26]
BlackRock Inc Adaptive Biotechnologies Corp [2023-02-13]
Ark Investment Management LLC Adaptive Biotechnologies Corp [2023-02-10]
Price T Rowe Associates Inc /MD/ Adaptive Biotechnologies Corp [2022-02-10]
View All
Form 3/4/5 Subject 2011 - 2026
Robins Harlan S
Adaptive Biotechnologies Corp
Bobulsky Susan
Lo Francis
Benzeno Sharon
Griffin Michelle Renee
Piskel Kyle
Rubinstein Julie
Robins Chad M
Owen Katey Einterz
Hershberg Robert
Neupert Peter M
Pellini Michael J
Taylor Stacy L
Peterson Tycho
Sood Nitin
Adams R Mark
Conroy Kevin T
Trigg Leslie
Baldo Lance
Cohen Chad M
Palaniappan Jyoti
Thorsen Henning
Matrix Capital Management Company LP
GOEL David E
Dobmeier Eric
Hill Nancy Louise
Viking Global Investors LP
Viking Global Equities II LP
Viking Long Fund Master Ltd
Viking Global Performance LLC
Halvorsen Ole Andreas
Shabet Rose Sharon
Viking Long Fund GP LLC
Viking Global Equities Master Ltd
Ott David C
Sang Charles
Viking Global Opportunities GP LLC
Viking Global Opportunities Illiquid Investments Sub-Master
Viking Global Opportunities Portfolio GP LLC
Zoltners Andris A
Nolan Sean Patrick
Viking Global Equities LP
VGE III Portfolio Ltd
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-31 Sell 19,060 $13.45 256,357
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-31 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-31 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-30 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-30 Sell 19,060 $12.63 240,728
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-30 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-27 Sell 2,738 $12.49 34,198
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-27 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-27 Sell 16,322 $13.48 220,021
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-27 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-26 Sell 19,060 $14.12 269,127
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-26 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-26 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-25 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-25 Sell 19,060 $14.27 271,986
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-25 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Stock Option (right to buy) · derivative
2026-03-24 Option exercise 14,722 $0.00
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-24 Option exercise 14,722 $7.27 107,029
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-24 Sell 19,060 $13.70 261,122
Adaptive Biotechnologies Corp ADPT
Common Stock
2026-03-23 Sell 19,060 $13.83 263,600
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com